Single Pass, Inc., a Lake Forest CA-based medical technology company, raised an undisclosed amount in seed funding.
The round was led by Tech Coast Angels of San Diego with participation from Kyto Technology and Life Science, Inc.
The company intends to use the funds to expand operations, accelerate growth and its business reach.
Led by Bill Colone, CEO, Single Pass provides an isposable bipolar electrocautery device that can cauterize deep tissue through a guide needle. According to the company, the patented device provides several clinical advantages and procedural cost savings for the millions of patients required to undergo deep tissue biopsy procedures every year.
The technology was invented by company co-founders Peter Sunenshine, MD, Chief of Neurointerventional Surgery and Kevin Hirsch, MD, Chairman Department of Radiology, both of Banner University Medical Center in Phoenix, Arizona.
The company is targeting 2022 for the commercial introduction of the new device both in the US and internationally.
FinSMEs
09/07/2021